The global ampoules packaging market is expected to grow at a Compound Annual Growth Rate of more than 8% until 2020, driven by the demand for more sustainable packaging materials, among other factors. That’s according to a new research report from Technavio titled, “Global Ampoules Packaging Market 2016-2020.”
“Increased environmental concerns among consumers have increased the demand for sustainable packaging materials, thereby influencing the ampoule packaging market,” says Sharan Raj, one of Technavio’s lead industry analysts for packaging. “Ampoules are made of conventional plastics, which do not decompose easily. Vendors are adopting sustainable materials to reduce the dependency on conventional plastics and adopt eco-friendly practices. The emergence of green plastics or biodegradable plastics will fuel the growth of the market during the forecast period.”
“These plastics are made from petrochemicals and contain biodegradable additives. They can be easily decomposed by microorganisms and produce less toxic gases compared to conventional plastics. Increased use of materials, including polyvinyl alcohol, polyanhydrides, and polylactic acid by plastic packaging manufacturers will reduce the market share of conventional plastics. Vendors in ampoules packaging are increasingly using biodegradable plastics to comply with stringent environmental regulations.”
Some of the other driving forces behind the growth of the global ampoules packaging market include:
• Increased prevalence of chronic diseases and infections
• Strict government regulations and standards
• Significant growth in emerging countries
Increased prevalence of chronic diseases and infections
Increased prevalence of chronic diseases (e.g., cancer and tuberculosis) and non-communicable diseases (e.g., diabetes and cardiovascular diseases) serves the ampoules packaging market as a driver. According to the International Diabetes Federation (IDF), the global prevalence of diabetes is projected to reach 592 million by 2035. In addition, the number of patients with infectious respiratory, gastrointestinal, and sexually transmitted diseases (HIV infection and AIDS) as well as hospital-acquired infections (such as methicillin-resistant Staphylococcus aureus) has also increased.
The rising number of chronic diseases is increasing the demand for vaccines and anti-thrombotic drugs in the market. Owing to these developments, the global market for antithrombotic drugs is projected to reach $21.6 billion by the end of 2018. Thus, the increased prevalence, early diagnosis, and regular monitoring of chronic diseases is likely to increase the demand for ampoules packaging during the forecast period.
Strict government regulations and standards
Strict government regulations and industry standards for packaging of pharmaceutical-related products have resulted in a positive impact on the market. According to FDA regulations in the U.S., pharmaceutical solutions or drugs need high-barrier packaging materials and sealants that are impermeable and resistant to solvents, grease, chemicals and heat. Government regulations in developed countries such as Japan and European countries demand greater barrier and security protection of medical supplies and devices.
In addition, for the supply of medical products produced nationally to the domestic and international markets, governments in developing countries such as China and India have upgraded their industry standards for ampoule packaging to maintain quality and safety, and reduce breakage, spillage and contamination. Thus, strict regulations and standards for packaging of pharmaceutical-related products are expected to fuel the growth of the ampoules packaging market until 2020.
Significant growth in emerging countries
Global ampoules product manufacturers are focusing on emerging countries such as Brazil, Russia, India, and China (BRIC) to expand their operations. These governments are taking initiatives to build healthcare infrastructures and increase healthcare budgets. They are also focusing on the improvement of diagnostic procedures. Due to air pollution and water contamination, there has been an increase in the prevalence of chronic and infectious diseases.
BRIC countries represent an attractive market for multinational corporations in the healthcare industry owing to the rising awareness among consumers about chronic and infectious diseases.
